Skip to main content
. 2026 Sep 22;14(10):836. doi: 10.3390/vaccines14100836
ARR Absolute risk reduction
GRADE Grading of Recommendations Assessment, Development and Evaluation
NNV Number needed to vaccinate
RR Risk ratio
RoB 2 Revised Cochrane Risk of Bias tool
CI Confidence interval
CYD-TDV Chimeric yellow fever dengue–tetravalent dengue vaccine
DENV Dengue virus
DENV-1 Dengue virus serotype 1
DENV-2 Dengue virus serotype 2
DENV-3 Dengue virus serotype 3
DENV-4 Dengue virus serotype 4
GMR Geometric mean ratio
GMT Geometric mean titre
I2 Inconsistency statistic
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
PROSPERO International Prospective Register of Systematic Reviews
TAK-003 Tetravalent dengue vaccine candidate
VCD Virologically confirmed dengue